Because neither component is an FDA-approved substance, the blend is not eligible for pharmacy compounding for human use
Legislation U.S
Pratley RE, Kang J, Trautmann ME, Hompesch M, Han O, Stewart J, et al
for context only Source type Animal pharmacology summaries Context Human research-community planning (subQ) Reported amount Sub-milligram per administration Notes Sparse direct human data Source type Community research planning, not formal trials Injectable subQ Semax has limited human evidence
And right here, this is where the low fat craze began and about fifteen percent of the US population was obese in nineteen eighty five, And by the twenty ten, two thousand and six, it was up to forty percent to fifty percent And Ive seen in some areas over seventy percent So So just like the Hashimotos autoimmune thyroid crisis that we fostered in the late 40s and early 50s, its really on us
#biopharma #obesity #GLP1 #drugdevelopment #innovation To view or add a comment, sign in Attention Regulatory professionals
